Literatur
- 1
Balin B J, Gerard H C, Arking E J, Appelt D M, Branigan P J, Abrams J T, Whittum-Hudson J A,
Hudson A P.
Identification
and localization of Chlamydia pneumoniae in the Alzheimers brain.
Med
Microbiol Immunol (Berl).
1998;
187
23-42
- 2
Bauriedel G, Andrié R, Likungu J A, Welz A, Braun P, Welsch U, Lüderitz B.
Persistenz
von Chlamydia pneumoniae in koronarem Plaquegewebe. Ein Beitrag
zur Infektions- und Immunhypothese bei instabiler Angina pectoris.
Dtsch
med Wschr.
1999;
124
1408-1413
- 3
Bauriedel G, Wlsch U, Likungu J A, Welz A, Lüderitz B.
Chlamydia pneumoniae
in koronarem Plaquegewebe: Vermehrter Nachweis bei akutem Koronarsyndrom.
Dtsch
med Wschr.
1999;
124
375-380
- 4
Birkebaek N H, Jensen J S, Seefeldt T, Degn J, Huniche B, Andersen P L, Ostergaard L.
Chlamydia pneumoniae
infection in adults with chronic cough compared with healthy blood
donors.
Eur Respir J.
2000;
16
108-111
- 5
Boman J, Roblin P M, Sundström P, Sandström M, Hammerschlag M R.
Failure
to detect Chlamydia pneumonae in the central nervous system of patients
with MS.
Neurology.
2000;
54
265
- 6
Chiu B.
Multiple
infections in carotid atherosclerotic plaques.
Am Heart
J.
1999;
138
S534-S536
- 7
Cook P J, Honeybourne D, Lip G Y, Beevers D G, Wise R, Davies P.
Chlamydia pneumoniae
antibody titers are significantly associated with acute stroke and
transient cerebral ischemia: The West Birmingham Stroke Project.
Stroke.
1998;
29
404-410
- 8
Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J.
Chlamydia
pneumoniae but not cytomegalovirus antibodies are associated with
future risk of stroke and cardiovascular disease: A prospective
study in middle-aged to elderly men with treated hypertension.
Stroke.
1999;
30
299-305
- 9
Ferrari M, Poli A, Olivieri M, Tardivo S, Biasin C, Balestreri F, Dal M olin
G, Lo C ascio V, Campello C.
Seroprevalence
of Chlamydia pneumoniae antibodies in a young adult population sample
living in Verona. European Community Respiratory Health Survey (ECRHS)
Verona.
Infection.
2000;
28
38-41
- 10
Fong I W.
Antibiotics
effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
J
Infect Dis.
2000;
181
S514-S518
(Suppl)
- 11
Gieffers J, Reusche E, Solbach W, Maass M.
Failure to detect Chlamydia
pneumoniae in brain sections of Alzheimers disease patients.
J
Clin Microbiol.
2000;
38
881-82
- 12
Glader C A, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen G H.
Chlamydia pneumoniae antibodies and high lipoprotein(a)
levels do not predict ischemic cerebral infarctions. Results from
a nested case-control study in Northern Sweden.
Stroke.
1999;
30
2013-2018
- 13
Gupta S, Leatham E W, Carrington D, Mendall M A, Kaski J C, Camm A J.
Elevated
Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin
in male survivors of myocardial infarction.
Circulation.
1997;
96
404-407
- 14
Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. ROXIS Study Group .
Randomised trial of roxithromycin
in non-Q-wave coronary syndromes: ROXIS Pilot Study.
Lancet.
1997;
350
404-407
- 15
Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B.
Treatment with the antibiotic
roxithromycin in patients with acute non-Q-wave coronary syndromes.
The final report of the ROXIS Study.
Eur Heart J.
1999;
20
121-127
- 16
Gurfinkel E.
Inflammation,
infection, or both in atherosclerosis: The ROXIS trial in perspective.
J
Infect Dis.
2000;
181
S566-S568
((Suppl)
- 17
Larsen F O, Norn S, Mordhorst C H, Stahl-Skov P, Milman N, Clementsen P.
Chlamydia pneumoniae
and possible relationship to asthma.
APMIS.
1998;
106
928-934
- 18
Laurila A L, von Hertzen L, Saikku P.
Chlamydia
pneumoniae and Chronic Lung Disease.
Scand J Infect Dis
Suppl.
1997;
104
34-36
- 19
Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler P, Grond-Ginsbach C,
Grau A J.
Evidence
for infection with Chlamydia pneumoniae in a subgroup of patients
with multiple sclerosis.
Ann Neurol.
2000;
47
652-655
- 20
Nochlin D, Shaw C M, Campbell L A, Kuo C C.
Failure to detect
Chlamydia pneumoniae in brain tissues of Alzheimers disease.
Neurology.
1999;
53
1888
- 21
Ross R.
Atherosclerosis:
An inflammatory disease.
N Engl J Med.
1999;
340
115-126
- 22
Saikku P.
Chlamydia
pneumoniae in atherosclerosis.
J Intern Med.
2000;
247
391-396
- 23
Shor A, Phillips J I.
Chlamydia
pneumoniae and Atherosclerosis.
JAMA.
1999;
282
2071-2073
- 24
Sriram S, Mitchell W, Stratton C.
Multiple
sclerosis associated with Chlamydia pneumoniae infection of the
CNS.
Neurology.
1998;
50
571-572
- 25
Sriram S, Stratton C W, Yao S, Tharp A, Ding L, Bannan J D, Mitchell W M.
Chlamydia
pneumoniae infection of the central nervous system in multiple sclerosis.
Ann
Neurol.
1999;
46
6-14
- 26
Sriram S, Stratton C W, Yao S, Tharp A, Ding L, Bannan J D, Mitchell W M.
Reply.
Ann
Neurol.
2000;
47
409-410
- 27
Stephenson J.
New
studies illuminate brain disorders.
JAMA.
1999;
281
499-501
- 28
Stille W, Stephan C.
Argumente für
eine Antibiotika-Therapie der multiplen Sklerose.
Arzneimitteltherapie.
1998;
16
370-373
- 29
Treib J, Haaß A.
Möglicher
Auslöser der Multiplen Sklerose.
Dt Ärztebl.
1999;
96
A2905-A2909
- 30
Treib J, Haass A, Stille W, Maass M, Stephan C, Holzer G, Morgenthaler M, Woessner R,
Grauer M T.
Multiple
sclerosis and Chlamydia pneumoniae.
Ann Neurol.
2000;
47
408
- 31
Wimmer M L, Sandmann-Strupp R, Saikku P, Haberl R L.
Association of
chlamydial infection with cerebrovascular disease.
Stroke.
1996;
27
2207-2210
Korrespondenz
Dr. med. Ralph Woessner
Neurologische Klinik Westpfalz-Klinikum
67655 Kaiserslautern
Phone: 0631/203-1040 oder 203-1792
Fax: 0631/203-1977
Email: r.woessner@gmx.de
